Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Prudential Financial Inc — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Prudential Financial Inc trades at $114.08 (market cap $38.76B). The key difference: Prudential Financial Inc is far larger — about 22.7× Nuvation Bio Inc. Class A Common Stock's market cap, and Prudential Financial Inc pays a 4.98% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Prudential Financial Inc for 145 Days on average.
| NUVB | PRU | |
|---|---|---|
Market Cap | $1.71B | $38.76B |
Volume | 5,448,712 | 1,604,078 |
Sector | Health | Financials |
52-Week High | $9.54 | $125.13 |
52-Week Low | $3.41 | $92.00 |
Typical Hold Time | 0 Days | 145 Days |
Enterprise Value | $1.30B | $67.54B |
Dividend Yield | — | 4.98% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Prudential Financial (PRU) trades at $113.53, down slightly by 0.01%. The stock exhibits a bearish technical trend with key support at $110, while fundamentals show a P/E of 10.19 and net income margin of 6.04%. Recent earnings beat expectations in Q1 and Q2 2026, and the company announced a strategic $3 billion capital rotation and $750 million cost savings plan (MarketBeat, 2026-09-17).
The outlook is mixed: valuation appears attractive with low P/E and P/S ratios, and higher interest rates may boost investment income. However, analyst consensus is cautious with a $105.67 price target below current levels, and technical indicators signal bearish pressure. Risks include execution of strategic initiatives and macroeconomic sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
